IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models. - Arcos J; Grunenwald F; Sepulveda D; Jerez C; Urbina V; Huerta T; Troncoso-Escudero P; Tirado D; Perez A; Diaz-Espinoza R; Nova E; Kubitscheck U; et al. (Cell death discovery, 2023)